Home
Finance
Bank Routing Numbers
FedWire
Stock Portfolio Generator
Technical Analysis of Stocks
Best Months to Buy or Sell Stocks
Games
Hangman - Hang 'Em High
Chess
Shuttles Game
Chemistry
Chemical Equation Balancer
Periodic Table of the Elements
Chemical Bond Polarity Calculator
Linear Algebra
Gauss-Jordan Elimination Calculator
Calculate Pivots
Factorize: A=LU
Inverse Matrix Calculator
Null Space Calculator
Column Space Calculator
Row Space Calculator
Multiply Two Matrices
AI
Genetic Algorithms
Genetic Algorithms Stock Portfolio Generator
Shuttles Game
Tic-Tac-Toe Game
Personality Profile
Checkers Game
Scripts
Scan for all machines running IIS in a domain
Extract data from a Microsoft Word document
Outlook Scripts
Excel Scripts
IT
How to Stop a DDOS Attack
Subnet Calculator
Fingerprint Web Server
Whois Lookup
InternetPeriscope
About
My Favorite Links
Resume
View My Profile on LinkedIn
View My Profile on DataCamp
View My Profile on Pluralsight
Back to FDA Applications sponsored by ALLERGAN SALES LLC
FDA Drug Application 020701 by ALLERGAN SALES LLC
Application Number
020701
Application Type
New Drug Application
Sponsor Applicant
ALLERGAN SALES LLC
Most Recent Label Available Flag
Current Patent Flag
Action Type
Approval
Chemical Type
New formulation
Therapeutic Potential
Standard
Orphan Code
Action Type
Duplicate Counter
Action Date
Document Type
Application Document ID
Sequence Number
Document Title
Document URL
Document Date
AP
0
7/31/1997
N
6449
000
http://www.accessdata.fda.gov/drugsatfda_docs/nda/97/020701_crinone_toc.cfm
8/8/2003
AP
0
2/17/1998
SCS
AP
0
12/11/1997
SCS
AP
0
12/16/1998
SCE
AP
0
4/3/2001
SLR
5024
007
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2001//20701S7ltr.pdf
4/11/2001
AP
0
4/20/2001
SCS
5025
009
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2001/20701S9ltr.pdf
4/23/2001
AP
0
4/20/2001
SCS
18525
009
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/020701_S009_CRINONE.pdf
11/19/2007
AP
0
9/17/2003
SLR
6704
011
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/20701slr011,20756slr012ltr.pdf
9/29/2003
AP
0
11/12/2003
SLR
6987
012
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/20701slr012ltr.pdf
11/26/2003
AP
0
3/23/2005
SLR
11298
014
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/20701s014ltr.pdf
3/29/2005
AP
0
3/23/2005
SLR
11304
014
http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/20701s014lbl.pdf
3/29/2005
AP
0
12/8/2011
SLR
30957
020
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/020701s020,s021,s023ltr.pdf
12/14/2011
AP
0
12/8/2011
SLR
30989
020
http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020701s020s021s023lbl.pdf
12/14/2011
AP
0
12/8/2011
SLR
30958
021
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/020701s020,s021,s023ltr.pdf
12/14/2011
AP
0
12/8/2011
SLR
30990
021
http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020701s020s021s023lbl.pdf
12/14/2011
AP
0
12/8/2011
SLR
30959
023
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/020701s020,s021,s023ltr.pdf
12/14/2011
AP
0
12/8/2011
SLR
30991
023
http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020701s020s021s023lbl.pdf
12/14/2011
AP
0
9/29/2015
SCM
AP
0
8/21/2013
SCM
36871
026
http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020701s026lbl.pdf
8/22/2013
AP
0
3/4/2014
SCM
Back to FDA Applications sponsored by ALLERGAN SALES LLC